Lexington Medical Secures Growth Investment from Ampersand Capital Partners

Lexington Medical, a leader in minimally-invasive surgical stapling solutions, has secured a strategic investment from Ampersand Capital Partners. This investment by Ampersand—a private equity firm specializing in growth equity within the healthcare and life sciences sectors—aims to bolster Lexington Medical's product innovation, smart manufacturing, and global market expansion. Lexington, founded in 2013 and based in Bedford, Massachusetts, produces endoscopic stapling devices renowned for their use in a variety of surgical procedures globally. With a patented portfolio of more than 40 SKUs, used in over 35 countries, Lexington is dedicated to driving continuous innovation. Ampersand's support exemplifies confidence in Lexington’s potential to redefine surgical stapling standards and expedite its strategic vision. The collaboration arises as Lexington plans to expand its team to cater to the increasing demand for its products. Interested parties can explore career opportunities through their website. Ampersand Capital has over $3 billion in assets, focusing on transformative investments in the healthcare sector—demonstrating a track record of building market-leading companies.